NEW YORK, Feb. 1, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Eliminate unnecessary risk with the industry benchmark in comprehensive patent information.
Pipeline Developer is a regularly updated, professional patent search performed by our expert team, which not only identifies relevant patents, but delivers categorisation and interpretation, all delivered by a convenient online interface.
This Pipeline Developer report covers Bevacizumab
Bevacizumab indications: In combination with 5-Fluorouracil based chemotherapy for metastatic carcinoma of the colon or rectum; in combination with Carboplatin and Paclitaxel for non-squamous, non-small cell lung cancer; in combination with Paclitaxel for metastatic breast cancer
Bevacizumab innovator: Roche (Avastin)
Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait.
Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Developer minimises the risk of wasted developments or legal action, by providing you with nothing less than the very best in comprehensive patent information. Searched and analysed by highly trained, dedicated staff using sophisticated searching techniques, Pipeline Developer delivers results you can rely on. And that means your staff can concentrate on how the patent landscape affects your business, rather than trying to source reliable patent information.
Pipeline Developer features: #